By Product
Currency:CNY
2025/H1
Stock NameRevenueRatio
药物开发及商业化阶段的产品和服务764.65M83.14%
药物研究阶段的产品和服务153.75M16.72%
Other1.33M0.14%
By Industry
Currency:CNY
2024/FY
Stock NameRevenueRatio
药物研发与生产相关业务1.69B100.00%
By Country/Region
Currency:CNY
2025/H1
Stock NameRevenueRatio
Foreign sales658.96M71.65%
Domestic sales260.77M28.35%
